how to use aod9604 AOD‑9604 Fat Loss Research in 2025: Late‑Night Hype, Quiet Data, and What Real People Actually Feel AOD-9604 - Peptide for Fat

Description

It is reported as orally active in rodents [1]

Oxid Med Cell Longev

The peptide appears to act through direct interaction with adipocytes (fat cells), potentially involving activation of hormone-sensitive lipase (HSL) and modulation of -adrenergic receptor signaling pathways

Because large studies did not show robust, reproducible weightloss outcomes, development as a formal obesity drug was discontinued, and AOD9604 today is typically used offlabel as a wellness or bodycomposition adjunct rather than an FDAapproved obesity medication

A Phase 2 study published in the New England Journal of Medicine in 2023 (Jastreboff et al.) reported substantial weight loss in participants with obesity